Catalyst Wire Dossier Catalyst Wire Dossier

CAR-Treg Cell Therapy (Chimeric Antigen Receptor Regulatory T Cell Therapy)

CAR-Treg · Sangamo Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-Treg Cell Therapy (Chimeric Antigen Receptor Regulatory T Cell Therapy), covering 2025-02-10 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients [Phase 1, Phase 2]

See pricing